Recce Ltd has released a press release.
Trading halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1566
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- R327 Phase I Clinical Trial Registered on ANZCTR
- Recce Receives Further Innovation Connections Grant
- Anti-Viral Patent Granted in USA for RECCE Anti-Infectives
- Anti-Viral Patent Granted in China
- Outstanding Efficacy Against Flesh-Eating Bacteria
Later from Recce Pharmaceuticals
- Suspension from Official Quotation
- Court Orders Granted
- Reinstatement to Official Quotation
- Ethics Approval to Start Phase 1 Intravenous Clinical Trial
- Appendix 4C and Activity Report
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals